Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.

Gut Liver · 2017 · PMC5593333 · PMID 28651304

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

a decreasing trendp=0.051so close (0.05 < p ≤ 0.1)

In subgroup analysis for NSBB responders, LPS, LBP, and IL-6 significantly decreased (LPS, p=0.008; LBP, p=0.008; IL-6, p=0.008), and TNF-α also showed a decreasing trend after treatment (p=0.051) in the combination therapy group ( Table 4 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.